Kavar Capital Partners Group, LLC Novo Nordisk A S Transaction History

Kavar Capital Partners Group, LLC

$630 Million
Q3 2024

A detailed history of Kavar Capital Partners Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 31,753 shares of NVO stock, worth $3.23 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

31,753

Previous 32,173 1.31%

Holding current value

$3.23 Million

Previous $4.59 Million 17.68%

% of portfolio

0.6%

Previous 0.83%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$119.07 - $145.42 $50,009 - $61,076	-420 Reduced 1.31%	31,753 $3.78 Million
Q2 2024 Jul 19, 2024	SELL	$122.71 - $146.91 $11,166 - $13,368	-91 Reduced 0.28%	32,173 $4.59 Million
Q1 2024 May 14, 2024	SELL	$102.11 - $135.92 $3.33 Million - $4.43 Million	-32,564 Reduced 50.23%	32,264 $4.14 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $2.84 Million - $3.41 Million	32,334 Added 99.51%	64,828 $6.71 Million
Q3 2023 Nov 06, 2023	BUY	$90.94 - $199.54 $1.42 Million - $3.11 Million	15,601 Added 92.35%	32,494 $2.96 Million
Q2 2023 Aug 07, 2023	SELL	$155.98 - $172.65 $2.41 Million - $2.67 Million	-15,479 Reduced 47.82%	16,893 $2.73 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $192,157 - $231,071	-1,452 Reduced 4.29%	32,372 $5.15 Million
Q4 2022 Feb 10, 2023	SELL	$102.55 - $135.33 $44,096 - $58,191	-430 Reduced 1.26%	33,824 $4.58 Million
Q3 2022 Nov 08, 2022	BUY	$95.28 - $116.93 $138,156 - $169,548	1,450 Added 4.42%	34,254 $3.41 Million
Q2 2022 Aug 09, 2022	SELL	$103.24 - $121.81 $67,106 - $79,176	-650 Reduced 1.94%	32,804 $3.66 Million
Q1 2022 May 09, 2022	SELL	$93.1 - $112.54 $17,689 - $21,382	-190 Reduced 0.56%	33,454 $3.72 Million
Q4 2021 Jan 27, 2022	SELL	$95.88 - $117.08 $6,711 - $8,195	-70 Reduced 0.21%	33,644 $3.77 Million
Q3 2021 Nov 01, 2021	SELL	$84.42 - $106.62 $21,105 - $26,655	-250 Reduced 0.74%	33,714 $3.24 Million
Q2 2021 Aug 02, 2021	SELL	$67.66 - $84.76 $40,596 - $50,856	-600 Reduced 1.74%	33,964 $2.85 Million
Q1 2021 May 13, 2021	SELL	$67.06 - $75.82 $57,001 - $64,446	-850 Reduced 2.4%	34,564 $2.33 Million
Q4 2020 Feb 05, 2021	BUY	$63.89 - $73.8 $2.26 Million - $2.61 Million	35,414 New	35,414 $2.47 Million

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.

Account

Kavar Capital Partners Group, LLC Novo Nordisk A S Transaction History